The Daffodil Centre, the University of Sydney, a joint venture with Cancer Council NSW, Sydney, Australia.
Sydney School of Public Health, Faculty of Medicine & Health, University of Sydney, Sydney, Australia.
Br J Radiol. 2023 Aug;96(1148):20230081. doi: 10.1259/bjr.20230081. Epub 2023 May 25.
This follow-up study of BreastScreen Victoria's pilot trial of digital breast tomosynthesis aimed to report interval cancer rates, screening sensitivity, and density-stratified outcomes for tomosynthesis mammography screening.
Prospective pilot trial [ACTRN-12617000947303] in Maroondah BreastScreen recruited females ≥ 40 years presenting for screening (August 2017-November 2018) to DBT; concurrent screening participants who received mammography formed a comparison group. Follow-up of 24 months from screen date was used to ascertain interval cancers; automated breast density was measured.
There were 48 screen-detected and 9 interval cancers amongst 4908 tomosynthesis screens, and 34 screen-detected and 16 interval cancers amongst 5153 mammography screens. Interval cancer rate was 1.8/1000 (95%CI 0.8-3.5) for tomosynthesis 3.1/1000 (95%CI 1.8-5.0) for mammography ( = 0.20). Sensitivity of tomosynthesis (86.0%; 95% CI 74.2-93.7) was significantly higher than mammography (68.0%; 95% CI 53.3-80.5), = 0.03. Cancer detection rate (CDR) of 9.8/1000 (95%CI 7.2-12.9) for tomosynthesis was higher than that of 6.6/1000 (95%CI 4.6-9.2) for mammography ( = 0.08); density-stratified analyses showed CDR was significantly higher for tomosynthesis than mammography (10.6/1000 3.5/1000, = 0.03) in high-density screens. Recall rate for tomosynthesis was significantly higher than for mammography (4.2% 3.0%, < 0.001), and this increase in recall for tomosynthesis was evident only in high-density screens (5.6% 2.9%, < 0.001).
Although interval cancer rates did not significantly differ between screened groups, sensitivity was significantly higher for tomosynthesis than mammography screening.
In a program-embedded pilot trial, both increased cancer detection and recall rates from tomosynthesis were predominantly observed in high-density screens.
本项研究是对维多利亚乳腺癌筛查计划数字乳腺断层摄影术的试点研究进行随访,旨在报告断层摄影术乳腺筛查的间期癌发生率、筛查敏感性和密度分层结果。
前瞻性试点研究[ACTRN-12617000947303]在 Maroondah BreastScreen 招募 40 岁以上进行筛查的女性(2017 年 8 月至 2018 年 11 月)接受数字乳腺断层摄影术筛查;同时接受乳腺 X 线摄影筛查的参与者构成对照组。使用筛查日期后 24 个月的随访来确定间期癌;自动乳腺密度测量。
在 4908 例数字乳腺断层摄影术筛查中发现 48 例筛查发现的癌症和 9 例间期癌,在 5153 例乳腺 X 线摄影筛查中发现 34 例筛查发现的癌症和 16 例间期癌。数字乳腺断层摄影术的间期癌发生率为 1.8/1000(95%CI 0.8-3.5),乳腺 X 线摄影术的间期癌发生率为 3.1/1000(95%CI 1.8-5.0)( = 0.20)。数字乳腺断层摄影术的敏感性(86.0%;95%CI 74.2-93.7)明显高于乳腺 X 线摄影术(68.0%;95%CI 53.3-80.5)( = 0.03)。数字乳腺断层摄影术的癌症检出率(CDR)为 9.8/1000(95%CI 7.2-12.9),高于乳腺 X 线摄影术的 6.6/1000(95%CI 4.6-9.2)( = 0.08);分层分析显示,在高密乳腺中,数字乳腺断层摄影术的 CDR 明显高于乳腺 X 线摄影术(10.6/1000 3.5/1000, = 0.03)。数字乳腺断层摄影术的召回率明显高于乳腺 X 线摄影术(4.2% 3.0%, < 0.001),而数字乳腺断层摄影术的这种召回率增加仅见于高密乳腺(5.6% 2.9%, < 0.001)。
尽管筛查组之间的间期癌发生率没有显著差异,但数字乳腺断层摄影术的敏感性明显高于乳腺 X 线摄影术。
在一项嵌入式试验中,数字乳腺断层摄影术在提高癌症检出率和召回率方面的优势主要见于高密乳腺。